A Molecular Diagnostics Company

Making Early Cancer Detection the New Standard of Primary Care

Our Mission

For heart disease, thyroid function and diabetes… frequent, recurrent, sequential monitoring and screening are standard of primary care in asymptomatic populations.

Our Science

Find out how we’re unlocking frequent, recurring monitoring for early cancer signal as the new standard of primary care.

Image

More accurate & reliable

Image

More cost effective

Image

fully scalable

Image

significant societal impact

Our Social Impact

Latest News

Acuamark CEO Bernard Peperstraete

AcuamarkDx Welcomes Two New Board Members

December 5, 2024

AcuamarkDx is pleased to announce the addition of Tim Gordon and Chiara Gabbi, MD, PhD, to ourboard of directors. Their expertise in financial strategy and clinical research will help guide us as we advance our groundbreaking early cancer detection technology through clinical development and toward commercialization.

Read more

Acuamark CEO Bernard Peperstraete

Acuamark at LSI Europe 2024

November 5, 2024

AcuamarkDx's Co-Founder and CEO Bernard Peperstraete recently presented to a full room at #LSIEurope24.

Bernard highlighted Acuamark's groundbreaking advancements in early cancer detection technology and shared insights into our innovative approach including proprietary qPCR and machine learning-driven assays, which achieve high sensitivity and specificity in detecting early-stage cancer.

Watch the presentation here:

https://www.youtube.com/watch?v=BMS7lVvWHt4&t=3s

Acuamark CEO Bernard Peperstraete

Acuamark on LinkedIn

October 10, 2024

AcuamarkDx's Co-Founder and CEO Bernard Peperstraete will be attending HLTH 2024 in Las Vegas later this month.

If you're interested in learning more about AcuamarkDx’sqPCR diagnostics technology for cancer screening + recurrence monitoring, please reach out to schedule a meeting with Bernard.

We hope to see you at the event!

bit.ly/4eBz17Z

AcuamarkDx logo

Acuamark Diagnostics develops technology that allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before cancer becomes untreatable.

Contact Us